Showing results (401-410 of 493) with videos related to

Sort By:
Pageof 50
The Journal of Biological Chemistry|July 17, 2015
Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril AbnormalitiesOlga Igoucheva, Vitali Alexeev, Carmen M Halabi, et al.
The American Surgeon|March 15, 2011
The inflammatory modulation effect of glutamine-enriched total parenteral nutrition in postoperative gastrointestinal cancer patientsChien-Yu Lu, Ying-Ling Shih, Li-Chu Sun, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 17, 2008
Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patientsChien-Yu Lu, Deng-Chyang Wu, I-Chen Wu, et al.
The Kaohsiung Journal of Medical Sciences|August 16, 2012
High preoperative ratio of blood urea nitrogen to creatinine increased mortality in gastrointestinal cancer patients who developed postoperative enteric fistulasHsing-Lin Lin, Chao-Wen Chen, Chien-Yu Lu, et al.
Plos One|June 11, 2013
Association between provider volume and healthcare expenditures of patients with oral cancer in Taiwan: a population-based studyLi-Fu Chen, Hsu-Chueh Ho, Yu-Chieh Su, et al.
Molecular and Cellular Biology|December 12, 2007
Fibulin-2 is dispensable for mouse development and elastic fiber formationFrancois-Xavier Sicot, Takeshi Tsuda, Dessislava Markova, et al.
BMC Cancer|August 21, 2009
Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatmentLi-Chu Sun, Koung-Shing Chu, Su-Chen Cheng, et al.
Nano Letters|May 3, 2013
Improving nanowire sensing capability by electrical field alignment of surface probing moleculesChia-Jung Chu, Chia-Sen Yeh, Chun-Kai Liao, et al.
The British Journal of Radiology|May 25, 2022
Clinical value of PET/CT in identifying patients with oligometastatic/oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisonsDayu Xu, Fan Yu, Tiantian Guo, et al.
Clinical and Translational Radiation Oncology|September 8, 2025
Prognostic factors, patterns of failure and re-irradiation in hypofractionated stereotactic radiotherapy-treated brain metastases from non-small cell lung cancerDayu Xu, Yechun Pang, Jinghan Qu, et al.
Pageof 50